NCT04400695 2024-01-24
A Study of RC48-ADC for the Treatment of Locally Advanced or Metastatic Breast Cancer With Low Expression of HER2
RemeGen Co., Ltd.
Phase 3 Unknown
Clinical Trials
5 trialsNCT04262804 2023-08-22
A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2+ MBC
Zai Lab (Hong Kong), Ltd.
Phase 2 Unknown
NCT02448797 2021-07-20
EVIDENCE
Betta Pharmaceuticals Co., Ltd.
Phase 3 Unknown
NCT01843647 2015-07-15
Neoadjuvant Therapy of Icotinib in Epidermal Growth Factor Receptor Mutated NSCLC Patients
Betta Pharmaceuticals Co., Ltd.
Phase 2 Unknown
NCT00641160 2008-09-26
Safety Study of Oral Vinorelbine in Subjects With Non-Hematologic Malignancies
Metronome Therapeutics
Phase 1 Unknown